These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 9345456

  • 1. B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus.
    Munch M, Møller-Larsen A, Christensen T, Morling N, Hansen HJ, Haahr S.
    Mult Scler; 1995 Jun; 1(2):78-81. PubMed ID: 9345456
    [Abstract] [Full Text] [Related]

  • 2. A putative new retrovirus associated with multiple sclerosis and the possible involvement of Epstein-Barr virus in this disease.
    Haahr S, Sommerlund M, Christensen T, Jensen AW, Hansen HJ, Møller-Larsen A.
    Ann N Y Acad Sci; 1994 Jun 06; 724():148-56. PubMed ID: 7518205
    [Abstract] [Full Text] [Related]

  • 3. Reverse transcriptase activity and particle production in B lymphoblastoid cell lines established from lymphocytes of patients with multiple sclerosis.
    Christensen T, Tönjes RR, zur Megede J, Boller K, Møller-Larsen A.
    AIDS Res Hum Retroviruses; 1999 Feb 10; 15(3):285-91. PubMed ID: 10052759
    [Abstract] [Full Text] [Related]

  • 4. Retrovirus-like particles in an Epstein-Barr virus-producing cell line derived from a patient with chronic progressive myelopathy.
    Sommerlund M, Pallesen G, Møller-Larsen A, Hansen HJ, Haahr S.
    Acta Neurol Scand; 1993 Feb 10; 87(2):71-6. PubMed ID: 8382893
    [Abstract] [Full Text] [Related]

  • 5. Higher incidence of Epstein-Barr virus-induced lymphocyte transformation in multiple sclerosis.
    Tørring C, Andreasen C, Gehr N, Bjerg L, Petersen T, Höllsberg P.
    Acta Neurol Scand; 2014 Aug 10; 130(2):90-6. PubMed ID: 24684660
    [Abstract] [Full Text] [Related]

  • 6. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH, Wolf H, Minarovits J.
    Autoimmunity; 2008 May 10; 41(4):298-328. PubMed ID: 18432410
    [Abstract] [Full Text] [Related]

  • 7. A human B-lymphoblastoid cell line constitutively producing Epstein-Barr herpesvirus and JHK retrovirus.
    Grossberg SE, Kushnaryov VM, Cashdollar LW, Raisch KP, Miller G, Sun HY.
    Res Virol; 1997 May 10; 148(3):191-206. PubMed ID: 9201810
    [Abstract] [Full Text] [Related]

  • 8. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines.
    Elliott J, Goodhew EB, Krug LT, Shakhnovsky N, Yoo L, Speck SH.
    J Virol; 2004 Dec 10; 78(24):14062-5. PubMed ID: 15564516
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
    Lai KY, Chou YC, Lin JH, Liu Y, Lin KM, Doong SL, Chen MR, Yeh TH, Lin SJ, Tsai CH.
    J Virol; 2015 Jun 10; 89(11):5968-80. PubMed ID: 25810549
    [Abstract] [Full Text] [Related]

  • 11. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
    Sugimoto M, Tahara H, Ide T, Furuichi Y.
    Cancer Res; 2004 May 15; 64(10):3361-4. PubMed ID: 15150084
    [Abstract] [Full Text] [Related]

  • 12. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
    Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, Stadelmann C, Gattenlöhner S, Owens GP, Gilden D, Bennett JL.
    Neurology; 2010 Apr 06; 74(14):1127-35. PubMed ID: 20220124
    [Abstract] [Full Text] [Related]

  • 13. Characterization of retroviruses from patients with multiple sclerosis.
    Christensen T, Jensen AW, Munch M, Haahr S, Sørensen PD, Riemann H, Hansen HJ, Møller-Larsen A.
    Acta Neurol Scand Suppl; 1997 Apr 06; 169():49-58. PubMed ID: 9174640
    [Abstract] [Full Text] [Related]

  • 14. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
    Hutchings IA, Tierney RJ, Kelly GL, Stylianou J, Rickinson AB, Bell AI.
    J Virol; 2006 Nov 06; 80(21):10700-11. PubMed ID: 16920819
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
    Kasprzak A, Spachacz R, Wachowiak J, Stefanska K, Zabel M.
    Folia Histochem Cytobiol; 2007 Nov 06; 45(3):169-79. PubMed ID: 17951165
    [Abstract] [Full Text] [Related]

  • 19. Establishment of retrovirus-, Epstein-Barr virus-positive B-lymphoblastoid cell lines derived from individuals at risk for acquired immune deficiency syndrome (AIDS).
    Casareale D, Sinangil F, Hedeskog M, Ward W, Volsky DJ, Sonnabend J.
    AIDS Res; 2007 Nov 06; 1(4):253-70. PubMed ID: 6085940
    [Abstract] [Full Text] [Related]

  • 20. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN, Stewart JP, Janjua NJ, Pepper SD, Sample C, Rooney CM, Arrand JR.
    Virology; 1995 Apr 20; 208(2):521-30. PubMed ID: 7538250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.